‘Rubeosis capsulare’ is an uncommon condition of neovascularisation within the lens capsule and is not amenable to conventional treatment modalities. 1 Bevacizumab, a humanised monoclonal anti-VEGF ...

SUNNYVALE, Calif., Jan. 3, 2013 -- Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic ...

Icon Bioscience announced that melphalan intraocular injection, the company’s investigational product for the treatment of retinoblastoma, has been granted Orphan Drug Designation by the FDA. Icon’s ...

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie ...

A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence. IVT is the primary method of delivering therapeutics in the eye, ...

The analysis included 41 patients who were treated with 136 intravitreal aflibercept, 8mg, injections. HealthDay News — The incidence of mild intraocular inflammation (IOI) in the real world occurs ...

Genentech, Inc. would like to inform you of important safety information regarding off-label intravitreal use of AVASTIN® (bevacizumab). As of December 8, 2008, Genentech, Inc. through its global ...

A new compound has been developed to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, with the ability to be administered by ophthalmic drops instead of ...